ME Therapeutics Holding (XCNQ:METX) ROE % Adjusted to Book Value : -0.86% (As of Feb. 2024)

View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding ROE % Adjusted to Book Value?

ME Therapeutics Holding's ROE % for the quarter that ended in Feb. 2024 was -65.15%. ME Therapeutics Holding's PB Ratio for the quarter that ended in Feb. 2024 was 75.86. ME Therapeutics Holding's ROE % Adjusted to Book Value for the quarter that ended in Feb. 2024 was -0.86%.

ME Therapeutics Holding ROE % Adjusted to Book Value Historical Data

The historical data trend for ME Therapeutics Holding's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding ROE % Adjusted to Book Value Chart

ME Therapeutics Holding Annual Data

Trend

Aug22

Aug23

ROE % Adjusted to Book Value

ME Therapeutics Holding Quarterly Data
	Aug22	Dec22	May23	Aug23	Nov23	Feb24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-	-	-	-10.20	-0.86

Competitive Comparison of ME Therapeutics Holding's ROE % Adjusted to Book Value

For the Biotechnology subindustry, ME Therapeutics Holding's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's ROE % Adjusted to Book Value falls into.

ME Therapeutics Holding ROE % Adjusted to Book Value Calculation

ME Therapeutics Holding's ROE % Adjusted to Book Value for the fiscal year that ended in Aug. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-3,326.53%	/	N/A
	=	N/A

ME Therapeutics Holding's ROE % Adjusted to Book Value for the quarter that ended in Feb. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-65.15%	/	75.86
	=	-0.86%

ME Therapeutics Holding ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

Q9T:Germany

Address

177 Robson Street, Vancouver, BC, CAN, V6B 0N3

Website

https://www.metherapeutics.com

ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines